ImmunoGen (IMGN) Completes 5.75 Million Share Offering
More News related to IMGN
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
- ImmunoGen (IMGN) Misses Q3 EPS by 2c; CFO Comments on Outlook
- Immunogen Inc. (IMGN) Posts Q1 Loss of $0.22; Reaffirms Guidance
- ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to Equity Offerings
- Allis-Chalmers Energy (ALY) Files $1.5B Mixed Securities Shelf
- Odyssey Marine Exploration (OMEX) Announces $50M Mixed Shelf
- Central Vermont Public Service (CV) Files $55M Common Shelf
- RehabCare Group (RHB) Announcess 4.35M Common Shelf Registration
- Brookdale Senior Living (BKD) Annouces 11M Common Offering from Selling Stockholders
ImmunoGen, Inc. (Nasdaq: IMGN) announced the completion of its previously reported public offering of 5,750,000 shares of common stock. The Company received net proceeds, after underwriting discounts and commissions and estimated expenses, of approximately $38.0 million.
ImmunoGen, Inc. develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies and the creation and linkage of potent cancer-cell killing agents (CKAs) to such antibodies. [SM]
Related Categories
Equity OfferingsStocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
